Fluidigm, ABI Agree to Drop Legal Skirmish | GenomeWeb

NEW YORK (GenomeWeb News) – Fluidigm and Life Technologies' Applied Biosystems business have agreed to end legal actions against each other related to Fluidigm's BioMark System, a Fluidigm spokesperson told GenomeWeb Daily Newstoday.

The firms agreed to dismiss the case, which was filed by Fluidigm against ABI in June 2008, last week, according to court documents. Howard High, the Fluidigm spokesman, told GWDN that the agreement does not include the exchange of any money or any licensing of products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.